HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%

Jonathan Shuter, Julie A. Sarlo, Tina J. Kanmaz, Richard A. Rode, Barry S. Zingman

Research output: Contribution to journalArticle

122 Scopus citations

Fingerprint Dive into the research topics of 'HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%'. Together they form a unique fingerprint.

Medicine & Life Sciences